The Rydel Seiffer tuning fork: an inexpensive device for screening diabetic patients with high-risk foot. Vijay V, C. Snehalatha, R. Seena, A. Ramachandran.Practical Diabetes Int. 2001: 18(5); 155-156
Routine foot examination: the first step towards prevention of diabetic foot amputation. Vijay V, Seena Rajasekar, C. Snehalatha, A. Ramachandran. Pract Diab Int June 2001. Vol 17, No.4.
Association between ACE gene polymorphism and diabetic nephropathy in south Indian patients.Vijay V, Yanqing Zhu, Karthik Bala, Stephen Dunn, C Snehalatha, A. Ramachandran, Muthu Jayaraman, Kumar Sharma. JOP. J. Pancreas (Online) 2001; 2 (2): 83 – 87.
Diabetic Nephropathy in Type 2 Diabetes: The Indian Experience.Vijay V. JAPI Dec 2001; Vol.49, 1185-187
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD. Diabetes Epidemiology Study Group in India (DESI). Diabetologia. 2001 Sep;44(9):1094-101.
Foot care economics--cost burden to diabetic patients with foot complications: a study from southern India.Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A.J Assoc Physicians India. 2001 May; 49: 530-3.
Risk variables for coronary artery disease in Asian Indians.Ramachandran A, Sathyamurthy I, Snehalatha C, Satyavani K, Sivasankari S, Misra J, Girinath MR, Vijay V. Am J Cardiol. 2001 Feb 1;87(3):267-71.
Association of proinsulin and insulin resistance with coronary artery disease in non-diabetic south Indian men.Snehalatha C, Ramachandran A, Saltyamurthy I, Satyavani K, Sivasankari S, Misra J, Vijay V. Diabet Med. 2001 Sep;18(9):706-8.
Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects.Snehalatha C, Vijay V, Suresh Mohan R, Satyavani K, Sivasankari S, Megha T, Radhika S, Ramachandran A. Diabetes Metab Res Rev. 2001 Nov-Dec; 17(6):444-7.
Periodontal diseases in Asian –Indian diabetes – a study from Southern India. Vinitha R, Khalid G, Vasanth Kumar, Vijay V, Snehalatha C, Ramachandran A. Int J Diab dev Countries 2001; 21: 129 – 131.
Prevalence of albuminuria among vegetarian and non-vegetarian south Indian diabetic patients.Vijay V, C Snehalatha, MP Varadharani, B Mamtha Nair, M Jayaraman, A Ramachandran.Indian J Nephrol 2002; 12: 73 – 76.
Prevalence of pathogens in diabetic foot infection in south Indian type 2 diabetic patients – Vijay V, J. Janifer Jasmine, C. Snehalatha, A. Ramachandran.JAPI, Vol. 50, Aug. 2002, 1013 – 1016.
Persistent microalbuminuria in type 1 diabetic subjects in south India.Vijay V, C Snehalatha, K Shina, A Ramachandran. JAPI 2002; 50: 1259 – 1261.
Early Recognition of Diabetic Neuropathy: Evaluation of a Simple Outpatient Procedure using Thermal Perception.Vijay V, C Snehalatha ,R Seena, A Ramachandran. Postgraduate Medical Journal 2002;Vol 78(923) Pg 541-542
Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India.Ramachandran A, Snehalatha C, Vijay V.Diabetes Res Clin Pract. 2002 Oct; 58(1):55-60.
Prevalence of overweight in urban Indian adolescent school children.Ramachandran A, Snehalatha C, Vinitha R, Thayyil M, Kumar CK, Sheeba L, Joseph S, Vijay V. Diabetes Res Clin Pract. 2002 Sep;57(3):185-90.
Impact of poverty on the prevalence of diabetes and its complications in urban southern India.Ramachandran A, Snehalatha C, Vijay V, King H. Diabet Med. 2002 Feb;19(2):130-5
Costs incurred by families having Type 1 diabetes in a developing country--a study from Southern India.Shobhana R, Rama Rao P, Lavanya A, Williams R, Padma C, Vijay V, Ramachandran A. Diabetes Res Clin Pract. 2002 Jan;55(1):45-8.
Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?.Snehalatha C, Ramachandran A, Sivasankari S, Satyavani K, Vijay V, Misra J, Girinath MR, Sathyamurthy I. J Assoc Physicians India. 2002 Aug;50:103
Plasma homocysteine concentration and coronary artery disease in Asian Indians.Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Sathyamurthy I, Vijay V.J Assoc Physicians India. 2002 Oct;50:1229-31.
Current and future perspective in the management of diabetes. Vishwanathan V. J Indian Med Assoc. 2002 Mar;100(3):181-3.
Increased carotid intimal media thickness precedes albuminuria in south Indian type 2 diabetic subjects.Vijay V, C Snehalatha, R Suresh Mohan, B Mamtha Nair, A Ramachandran.The British Journal of Diabetes and vascular disease Vol 3, issue 2, March / April 2003, pg: 146 – 149.
Association of limited joint mobility and high plantar pressure in diabetic foot ulceration in Asian Indians. Vijay V, C. Snehalatha, M. Sivagami, R Seena, A. Ramachandran.Diabetes research and clinical practice, April 2003; 60 (1), pg 57 – 61.
Regional differences in risk factors and clinical presentation of diabetic foot lesions.Vijay V, S. Morbach, J.K. Lutalet, J. Mollenberg, H.R. Ochs, Seena Rajasekar, A. Ramachandran, Z.G. Abbas. Diabetic medicine 2003; 21: 91 – 95.
Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients.Vijay V, Uma Mahesh, M Jayaraman, K Shina, A Ramachandran. JAPI, Vol. 51, January 2003.
Validation of indigenously made biothesiometer.Vijay V, Sanjeev V, Kelkar DK, Seena R, Mamtha B Nair, A Ramachandran.The Asian Journal of Diabetology, 2003; 5(3): 13 – 14.
Effect of treatment with the combination of Alpha – lipoic acid, chromium and inositol on diabetic peripheral neuropathy. Vijay V, HR Badrinath, C. Snehalatha, R.M. Bhoopathy , B. Mamta Nair, R Seena, M.P. Varadha Rani, A Ramachandran.The Asian Journal and Diabetology, September 2003, Vol. 5 (9); Pg. 9 – 15.
Diabetes could cost you your kidneys, act now!.Vijay V. JAPI November 2003, vol. 51, 1043 – 1044.
Validation of a method to determine albumin excretion rate in type 2 diabetes mellitus.Vijay V, C Snehalatha, B Mamtha Nair, A Ramachandran.Indian Journal of Nephrology 13; 2003: 85 – 88.
Type 2 diabetes in Asian-Indian urban children.Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V.Diabetes Care. 2003 Apr;26(4):1022-5.
Evaluation of the beta cell response by C-peptide measurement in parents of children with type I diabetes.Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Nanditha R, Vijay V, Hitman GA.J Assoc Physicians India. 2003 Sep;51:927-8.
Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians.Snehalatha C, Ramachandran A, Sivasankari S, Satyavani K, Vijay V. Diabetes Metab Res Rev. 2003 Jul-Aug; 19(4):329-32
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts.Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, Ramachandran A, Mohan V, Iyer SR, Tominaga M, Kiyohara Y, Kato I, Okubo K, Nagai M, Shibazaki S, Yang Z, Tong Z, Fan Q, Wang B, Chew SK, Tan BY, Heng D, Emmanuel S, Tajima N, Iwamoto Y, Snehalatha C, Vijay V, Kapur A, Dong Y, Nan H, Gao W, Shi H, Fu F; DECODA Study Group. Diabetes Care. 2003 Jun;26(6):1770-80.
Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria.Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Diabetes Res Clin Pract. 2003 Jun;60(3):199-204.
Quality of life and diabetes integration among subjects with type 2 diabetes. Shobhana R, Rama Rao P, Lavanya A, Padma C, Vijay V, Ramachandran A. J Assoc Physicians India. 2003 Apr;51: 363-5.
Impaired fasting glucose and impaired glucose tolerance in urban population in India.Ramachandran A, Snehalatha C, Satyavani K, Vijay V. Diabet Med. 2003 Mar;20(3):220-4.
Cutoff values for normal anthropometric variables in asian Indian adults.Vijay V, Ramachandran A.Snehalatha C. Diabetes Care. 2003 May; 26(5):1380
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians.Snehalatha C, Mukesh B, Simon M, Vijay V, Haffner SM, Ramachandran A. Diabetes Care. 2003 Dec;26(12):3226-9.
Effectiveness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. Vijay V, Madhavan S, Gnanasundaram S, Gopalakrishna G, Das BN, Seena R, Ramachandran A. Diabetes Care. 2004 Feb;27(2):474-7.
Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects. Vijay V, Snehalatha C, Nair MB, Ramachandran A. J Diabetes Complications. 2004 Jan-Feb;18(1):47-52.
Increased forefoot to rear foot plantar pressure ratio in South Indian patients with diabetic foot ulceration. Vijay V, Sivagami M, Seena R, Snehalatha C, Ramachandran A, Veves A. Diabet Med. 2004 Apr;21(4):396-7..
Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India.Ramachandran A, Snehalatha C, Baskar AD, Mary S, Kumar CK, Selvam S, Catherine S, Vijay V. Diabetologia. 2004 May; 47(5):860-5.
Specific problems of the diabetic foot in developing countries. Ramachandran A. Diabetes Metab Res Rev. 2004 May-Jun;20 Suppl 1:S19-22.
Use of glimepiride and insulin sensitizers in the treatment of type 2 diabetes--a study in Indians. Ramachandran A, Snehalatha C, Salini J, Vijay V. J Assoc Physicians India. 2004 Jun; 52:459-63.
Detecting undiagnosed diabetes in urban Asian Indians--role of opportunistic screening. Ramachandran A, Snehalatha C, Vijay V, Colagiuri S. JAPI 2004; 52(7): 545-6.
Flow mediated dilatation and carotid intimal media thickness in South Indian type 2 diabetic subjects. Nair BM, Vijay V, Snehalatha C, Mohan RS, Ramachandran A. Diabetes Res Clin Pract. 2004 Jul; 65(1):13-9.
Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian population. Jackson AE, Cassell PG, North BV, Vijayaraghavan S, Gelding SV, Ramachandran A, Snehalatha C, Hitman GA. Diabetes. 2004 Aug; 53(8):2122-5.
Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Borch-Johnsen K, Colagiuri S, Balkau B, Glümer C, Carstensen B, Ramachandran A, Dong Y, Gao W. Diabetologia. 2004 Aug;47(8):1396-402.
Low risk threshold for acquired diabetogenic factors in Asian Indians. Ramachandran A, Snehalatha C, Vijay V. Diabetes Res Clin Pract. 2004 Sep;65(3):189-95.
Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Vijay V Snehalatha C, Kumutha R, jayaraman M, Ramachandran A. Ind J Nephropathy. 2004 Jul-Sep 14(3): 89-92
Impact of Joint National Committee VII recommendations on diabetic microvascular complications. Vijay V, Snehalatha C, Kumutha R, Nair BM, Ramachandran A. J Assoc Physicians India. 2004 Nov; 52:873-6.
Diabetes & obesity -- the Indian angle. Ramachandran A. Indian J Med Res. 2004 Nov; 120 (5):437-9.
Increasing trend in prevalence of diabetes in rural south Asian countries undergoing social transition. Ramachandran A, Snehalatha C. Int J Metabolism by Fax 02/11/2004.
Contemporary diabetes care: An Integrated approach. Ramachandran A. Int J Metabolism. 14/12/2004.
Diffuse interstitial skeletal hyperostosis (DISH) in type 2 diabetes. Ghosh B, Kishore S, Vijay V, Ramachandran A. J Assoc Physicians India. 2004 Dec; 52:994-6.
The EIF2AK3 gene region and type I diabetes in subjects from South India.Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell PG, North BV, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot PJ, Hemmatpour SK, Froguel P, Hitman GA. Genes Immun. 2004 Dec;5(8):648-52.
Nerve conduction abnormalities in different stages of glucose intolerance. Vijay V, Seena R, Nair MB, Snehalatha C, Bhoopathy RM, Ramachandran A. Neurol India. 2004 Dec;52(4):466-9.
Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Engelgau MM, Colagiuri S, Ramachandran A, Borch-Johnsen K, Narayan KM; Atlanta Meeting Group. Diabetes Technol Ther. 2004 Dec;6(6):874-82. Review.
Socio-economic determinants of the cost of diabetes. Kapur A, Bjork S, Nair J, Kelkar S, Ramachandran A. Diabetes Voice 49(3): 18-21.
Prevention of diabetic nephropathy: A Diabetologist’s perspective. Vijay V. Ind J Nephrology 2004 Oct – Dec 14(4): 157-162.
Dietary management of diabetes mellitus in Indian and south east asia. Ramachandran A, Snehalatha C, Vijay V. Int. text book Diabetes Mellitus. Chapter 40
Type 2 Diabetes – Consequences of urbanizations. Ramachandran A. Type 2 Diabetes: Urban – Rural Chapter 1 pub micro labs.
Micro vascular complications in Type 2 Diabetes. Vijay V, Mamatha Nair, Sivagami N. Type 2 Diabetes: Urban – Rural. Published by Micro Labs.
Diabetes Mellitus. Ramachandran A, Snehalatha C. Public Health Nutrition. 2004; Chapter 20: 330 – 340.
Epidemiology of diabetes in India--three decades of research. Ramachandran A. J Assoc Physicians India. 2005 Jan;53:34-8.
Use of Metformin in Pregnancies with Diabetes:A Case Series from India
A Ramachandran, C Snehalatha, S Vijayalakshmi, Vijay V. J Assoc Physicians India 2005 Feb;157 – 158
Microalbuminuria: A Risk favtor for abnormal pulse wave velocity. Vijay V, Sheethal S, Mamtha BN, Snehalatha C, Ramachandran A. Ind J Cardiology 2005; 8: 9 – 12.
Comparative assessment of cystatin C and creatinine for determining renal function. Vijay V, Snehalatha C, Mamtha BN, Ramachandran A. Ind J Neprology 2005;15: 91 -194.
Improving psycho-social care: the Indian experience. Shobana R, Augustina C, Vijay V, Ramachandran A. Diabetes Voice 2005; 50(1):19 – 20.
An inexpensive method to diagnose incipient diabetic nephropathy in developing countries. Vijay V, Mamtha BN, Suresh S, Snehalatha C, Ramachandran A. Diabetes Care. 2005 May; 28(5):1259-60.
Experiences of the WHO collaborating centre for diabetes in India in managing tsunami Victims with diabetes. Ramachandran A. Pract diab Int 2005; 22(3): 98 – 99.
Amputation prevention initiative in South India: positive impact of foot care education. Vijay V, Madhavan S, Rajasekar S, Snehalatha C, Ramachandran A. Diabetes Care. 2005 May; 28(5):1019-21.
Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects. Vijay V, Snehalatha C, Nair MB, Kumutha R, Ramachandran A. Diabetes Metab Res Rev. 2005 May-Jun;21(3):276-80.PMID:15586391
Early diabetes control is vital prevent fatality from MI and stroke. Summary and comment by Ramachandran A. Int Diab Monitor 2005; 17(3) 22 – 23.
Serum triglycerides as a marker of insulin resistance in non-diabetic urban Indians. Snehalatha C, Satyavani K, Sivasankari S, Vijay V, Ramachandran A. Diabetes Res Clin Pract. 2005 Aug;69(2):205-6. PMID:16005371
Development of a Reliable and Valid Psychosocial Measure of Self-Perception of Health in Type 2 DiabetesPR Rao, R Shobhana, A Lavanya, C Padma, V Vijay, A Ramachandran JAPI 2005;53(8): 689 – 692.
Coronary risk variables in young asymptomatic smokers. Ramachandran A. Indian J Med Res. 2005 Sep; 122(3):191-2.
Diabetic Foot: An Indian Scenario. Vijay V, Sivagami, Seena R. Asian J Dibetology 2005; 7(3): Jul - Sep 9 – 11.
Socio – economic Issues in diabetic Foot. Ramachandran A. 2005; 7(3): 17 – 19.
Positive impact of education to prevent foot problems in developing countries. Sivagami M, Vijay V. Asian J Diabetology 2005; 7(3): 34 – 35.
Management of diabetes in Chronic renal failure. Vijay V. Indian J Nephrology. 2005;15 Supli 1: S23 – S31.
High incidence of glucose intolerance in Asian-Indian subjects with acute coronary syndrome. Ramachandran A, Snehalatha C, Immaneni S, Shanmugam RM, Vishnu N, Vijay V, Jaakko T. Diabetes Care. 2005 Oct;28(10):2492-6.
Derivation and validation of diabetes risk score for urban Asian Indians. Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S. Diabetes Res Clin Pract. 2005 Oct;70(1):63-70. PMID:16126124
Profile of diabetic foot complications and its associated complications--a multicentric study from India. Vijay V, Thomas N, Tandon N, Asirvatham A, Rajasekar S, Ramachandran A, Senthilvasan K, Murugan VS, Muthulakshmi. J Assoc Physicians India. 2005 Nov;53: 933-6.
Epidemiology of diabetes in India: three decades of research. Ramachandran A. API Medicine Update 2005 Ed by S B Gupta 2005; Vol 15: 177, Chapter 36.
Diabetic foot in India. Vijay V, Sharad Pendsey, Arun Bal. API Medicine Update 2005 Ed by S B Gupta 2005; Vol 15: 220 - 222, Chapter 47.
Safety of combination lipid lowering therapy. Vijay V. API Medicine Update 2005 Ed by S B Gupta 2005; Vol 15: 244 - 246, Chapter 52.
Handbook of Diabetes foot care. Ed by Sanjeev Kelkar. Contributors are Arun Bal, Das AK, pendesy S, Suresh KR, Vijay V, Ambardekar P
Socio-economic issue in diabetic foot. Ramachandran A. Proceeding of the 2nd Indo – Us workshop on Diabetic foot complication: Theme: Preventing diabetic amputations in developing countries. IJCP Group of Publications. Ed by Vijay V 2005; 46 – 48
Magnitude of diabetic foot problem in India. Vijay V. Proceeding of the 2nd Indo – Us workshop on Diabetic foot complication: Theme: Preventing diabetic amputations in developing countries. IJCP Group of Publications. Ed by Vijay V 2005; 49 – 50.
Multiple risk factors and low risk threshold for diabetes in Indians. Ramachandran A and Snehalatha C. Book chapter from Diabetes mellitus epidemic combat the challenge 2005; 17 – 24.
Recent status in the drug development to prevent diabetic complications. Vijay V and Kumutha R. Book chapter from Diabetes mellitus epidemic combat the challenge 2005; 54 – 66.
Elderly diabetes is a major health problem of the 21st century. Ramachandran A. Type 2 diabetes in the elderly, Micro Labs. 2005; 12 – 16.
Urological problems in elderly diabetic patients. Prakash JVS and Vijay V. Type 2 diabetes in the elderly. Pub by Micro Labs. 2005; 105 – 112.
Clustering of cardiovascular risk factors in Asian Indians. Ramachandran A. Book chapter from Coronary artery disease: Risk promoters, patho physiology and prevention Ed by Gundu HR Rao, Jaypee Publishers, 2005; chapter 2: 12 – 20.
High prevalence of abnormal glucose metabolism in subjects with acute coronary syndrome. Snehalatha C, Ramachadran A. Int J Metabolism by Fax. 31/01/2006.
Diabetes risk score. Snehalatha C, Ramachadran A. Int J Metabolism by Fax. 21/02/2006.
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). Diabetologia. 2006 Feb;49(2):289-97. PMID:16391903
The diabetes attitudes wishes, and needs (DAWN) progr am: A New approach to improving outcomes of diabetes care. Skovlnd SE, Peyrot M on behalf of DAWN Int Advisory Panel (Ruth Colagiuro, Ramachandran A etc). Diabetes Spectrum (Asian Edition) 2005; 5(1): 3 – 7.
Persistent impaired glucose tolerance has similar rate of risk factors as for diabetes--results of Indian diabetes prevention programme (IDPP).Ramachandran A, Snehalatha C, Mukesh B, Simon M, Kumar CK, Vijay V. Diabetes Res Clin Pract. 2006 Jul;73(1):100-3.PMID:16406189
Stress and undetected hyperglycemia in southern Indian coastal population affected by tsunami.Ramachandran A, Snehalatha C, Yamuna A, Bhaskar AD, Simon M, Vijay V, Shobhana R. J Assoc Physicians India. 2006 Feb; 54:109-12.PMID:16715612
Pregabalin: A Novel agent for neuropathic pain. Vijay V. Asian J Diabetology. 2006; 8(1): 9 – 13.
Arguments for and against the use of ACE inhibitors and ARBs in the treatment diabetic nephropathy. Vijay V, Mamtha BM. Asian J Diabtolo 2006; 8(1): 39 – 47.
Urban-rural differences in the prevalence of foot complications in South-Indian diabetic patients. Vijay V, Madhavan S, Seena R, Snehalatha C, Ramachandran A. Diabetes Care. 2006 Mar; 29(3):701-3.
Primary prevention of diabetes in the Asian population. Ramachandran A. Int. J Metabolism by Fax 23/05/2006.
A Phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-DTM 150)in healing diabetic foot ulcers. Vijay V Pendsey S, Sekar N, Murthy GSR. Wounds 2006; 18(7): 186 – 196.
How should developing countries manage diabetes? CMAJ Narayan KM, Zhang P, Williams D, Engelgau M, Imperatore G, Kanaya A, Ramachandran A. CMAJ. 2006 Sep 26;175(7):733.
A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy). Vijay V, Chacko PT, Lavanya M, Tilak P. J Assoc Physicians India. 2006 Dec;54:965-6.
Insulin resistance – is it a threat among Asian Indians? Ramachandran A. Book chapter from Type 2 Diabetes and the role of insulin resistance – micro laps 2006; 13 – 20.
Kidney in insulin resistance. Vijay V, Mamtha M. Book chapter from Type 2 Diabetes and the role of insulin resistance – micro laps 2006; 81 – 87.
Recent international developments: India. Vijay V. Chapter 33, “The Foot Diabetes”. 4th Ed Ed by Andrew J M, Boulton PR. 2006 John Wiley & sons. Ltd.
A focus group study among type 2 diabetic subjects. Shobana R, Christina R, Rao PR, Margaret M, Vijay V, Ramachandran A. JAPI 2007; 55(1):84-85.
Increasing expenditure on health care incurred by diabetic subjects in a developing country A study from India. Ramachandran A, Shobana R, Snehalatha C, Christina Augustine, Murugesan N, Vijay V, Kapoor A Williams R. Diabetes care 2007;30(2):252-256.PMID:17259490
Metabolic syndrome does not increase the risk of conversion of IGT to DM in Asian Indians: Results of IDDP. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. DRCP 2007; 76(2):215 – 218.PMID:16982107
Insulin resistance and clustering cardio metabolic risk factors in urban teenagers in southern India. Ramachandran A, Snehalatha C, Yamuna A, Murugesan , Venkat Narayan KM,. Diabetes care 2007; 30(7):1828-1833
Parental influence on the spectrum of type 2 diabetes in the offspring among Indians. Ramachandran A, Snehalatha C, Sivasankari S, Hit man GA, Vijay V. JAPI 2007;55(8):560-562.
Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. DRCP 2007;77(3):433-437.
Risk of future diabetes is as high with abnormal intermediate post glucose response as with impaired glucose tolerance. Vijay V, Clementina M, Mamta Nair B, Satyavani K. JAPI 2007;55(12): 833-837.
The Diabetic foot: Perspectives from Chennai, South India. Vijay V. Int J of Lower Extremity Wounds 2007; 6(1) : 34 – 36.
Prevention of type 2 diabetes: A review. Hussain A, Claussen B, Ramachandran A, Williams R. Diab. Resear. Cli Pract 2007; 76: 317 – 326.
Exercise and Diabetes mellitus. Vijay V. Asian J Diabetology; 2007: 10 – 11
Yoga as an adjunct therapy for type2 Diabetes mellitus. Vijay V. Asian J Diabtology; 2007: 37 – 38.
Diabetic Foot. Vijay V. Physician’s Digest April – May 2007; 16(1): 7 – 13
The diabetic foot in Africa and India. Zulfiqarali G. Abbas and Vijay V. International Diabetes Monitor 2007; 19(1): 8 – 12.
Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India.Ramachandran A, Snehalatha C, Yamuna A, Murugesan N, Narayan KM.Diabetes Care. 2007 Jul;30(7):1828-33.PMID:17416794
Epidemiology of Type 2 diabetes and its complications in India. Ramachandran A. Moses Manual on Diabetes Mellitus Ed by Sidharsha Das and Anand Moses IJCP publications 2007; 36 – 45. Chapter 5
Diabetic Nephropathy. Vijay V and Mamtha B Nair. Moses Manual on Diabetes Mellitus Ed by Sidharsha Das and Anand Moses IJCP publications 2007; 273 – 283. Chapter 31.
Diabetic renal – retinal syndrome. Vijay V and Mamtha B Nair. Moses Manual on Diabetes Mellitus Ed by Sidharsha Das and Anand Moses IJCP publications 2007; 284 – 289. Chapter 32.
Diabetic foot and its complications. Vijay V and Sivagami M. Moses Manual on Diabetes Mellitus Ed by Sidharsha Das and Anand Moses IJCP publications 2007; 292 – 299. Chapter 33.
Wolfram syndrome. Vijay V, Medumpudi S, Kadiri M. JAPI 2008; 56(3):197-199.
Effect of taurine and acetyl cysteine in attenuating micoalbuminuria in type 2 diabetes. Vijay V, Nair MB, Tilak P. Indian journal of Nephrology 2008;18(2):85.
Warm immersion recovery test in assessment of diabetic neuropathy – a proof of concept study. Manish Bharara, Vijay V, Cobb J E. Int. J Wounds 2008; 5 : 570-576.
Cold immersion recovery test in assessment of diabetic neuropathy – a proof of concept study. Manish Bharara, Vijay V, Cobb J E. Int. J Wounds 2008; 5 : 570-576.
Limited joint mobility and plantar pressure in type 1 diabetic subjects in India. Vijay V, Sivagami M, Seena R, Satyavani K. JAPI 2008;56(7):509-511.
High prevalence of metabolic syndrome and cardiovascular risk among police personnel compared to general population in India. Shabana T, Satyavani K, Muthukumaran P, Vijay V. JAPI 2008; 56(11):845-849
Three siblings with woodhouse – sakati syndrome in an Indian family. Koshy G, Danda S, Thomas N, Mathews V, Vijay V. Clinical Dysmorphology 2008; 17: 57 – 60.
Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study. IndINep study group. Pain Practice 2008; 8: 362 – 378.
levels of glycated albumin at different stages diabetic nephropathy in India. Vijay V, Satyavani K, Priyanka Tilak, Parthiban M. Int J Diabetese & Metabolism 17: 77 – 80; 2009
Cost of medical care among type 2 diabetic patients with a co morbid condition – hypertension in India. Shabana T, Satyavani K, Vijay V DRCP 83: 263 – 267; 2009
Assessment of ulcer related outcomes in type 2 diabetic patients with foot ulceration in India. Vijay V, Satyavani K, Saraswathi G, Gautham G, Bhadendeanth Das. J diabetic foot complications 1(2)no 3 40 – 6; 2009.
Gestational diabetes mellitus. Mitalee Hazarika. IMA Assam Sate branch calling Vol 8(2 & 3) 18 – 19, April – Sep 2009.
New Era in Diabetes. Hemanga Barman. IMA Assam State branch calling Vol 8 (2 & 3)31 – 32, April – Sep 2009.
Impact of socioeconomic status on prevalence of overweight and obesity among children and adolescents in urban India. Shabana T, Vijay V. The Obesity journal 1; 9 – 14; 2009
ACCROD..ing to advance a safe treatment strategy for near normal glycemic control in type 2 diabetes. Vijay V. TAPIJ 1(1): May – Aug; 10 – 12; 2009
Prevalence of lower urinary tract infection in south Indian type 2 diabetic subjects. J Jenifer, Geethalakshmi S, Satyavani K, Vijay V. IJN 19(3): 108 – 112; 2009
Severity of erectile dysfunction and prevalence of premature ejaculation among type 2 diabetic men referred to an ED Clinic of teritiary care centre. Vijay V, Sarweswar Agarwal, Satyavani K. JAPI 57(8); 604; 2009
Prevalence of metabolic syndrome among Asian Indian subjects with elevated intermedicine glucose response during OGTT. Vijay V, Satyavani K, Clementia M, Priyanka Tilak.DRCP 83: e17 – e18; 2009
Microalbuminuria: A Peril for cardiovascular disease. Priyanka Tilak, Satyavani K, Vijay V. Asian J Diabetology 11(3); 27 – 32; 2009
Oxidative stress markers regulating the healing of foot ulcers in patients with type 2 diabetes. Shiny John Vairamon, Mary Babu, Vijay V. Wounds: a CCRP. 21(10): 273 – 279; 2009
Prevention of diabetes by Lifestyle modification. Vijay V, Shabana Thaekar. Samvriddhi – CII News Letter, 11 – 13, 2009
Development and evaluation of a training programme on primary prevention of diabetes for primary care physicians. Shabana T, kathiresan K, Abraham P, Vijay V. Int J health research 2(4): 305 – 314; 2009.
Sitagliptin: The First in a new class of DPP – 4 inhibitors for the treatment of type 2 diabetes. Vijay V. TAPIJ 1(2): sep – Dec 2009
Biochemical parameters and hormonal profile in diabetes. Snehalatha C, Vijay V. RSSDI – Text book of Diabetes Mellitus, Chapter 21, page 335 – 352.
Pathogenesis of diabetic Micro vascular complications. Vijay V. RSSDI – Text Book of Diabetes Mellitus Vol I& II 2009, Chapter 65, page: 973 – 987.
Prevention of type 2 diabetes and its complications: The Indian perspective. Vijay V Shabana Tharkar, Priyanka Tilak. API Medicine Update, Chapter 40: 359 – 365.
Prevention of diabetic nephropathy: The Indian experience. Vijay V, Priyanka Tilak. Type 2 Diabetes and it complications: A Preventive Program. Micro Labs Ltd: 144 – 149.
2010 (9 NATION 6 Int Nat 2 BC 4 Sta L)
Comparative analysis of transcription factors of insulin signaling (Insulin receptor substrate family). Sampoornam B, Satyavani K, Vijay V. Ind J Biotech 9 (Jan), 2010:24 – 30.
Prevalence, aetiology and management of diabetic nephropathy: Indian overview. Vijay V, Tilak P. J of Gen Med, Jan – Mar,22 (1), 2010: 25 – 29.
Can the Divide be bridged: Overview of Life in Urban Slums in India.Vijay V, Tharkar S. Indian J Community Med. 2010 Jan;35(1):198-9.
Chennai slim and fit programme: Awareness and perceptions related to obesity among urban children and adolescents. Tharkar S, Vijay V. TAPI J 2(1) jan – April, 2010: 19 – 22.
Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects. Janifer J, Geethalakshmi S, Satyavani K, Vijay V. Indian J Nephrol. 2010 Apr;20(2):120.
Knowledge and Outcome Measure of HbA1c Testing in Asian Indian Patients with Type 2 Diabetes from a Tertiary Care Center. Kumpatla S, Medempudi S, Manoharan D, Vijay V. Indian J Community Med. 2010 Apr;35(2):290-3.
Clinical significance of urinary Monocyte Chemoattractant Protein-1 (uMCP-1)in Indian type 2 diabetic patients at different stages of diabetic nephropathy Priyanka Tilak, Zenith Khashim, Satyavani Kumpatla, Mary Babu, Vijay V. International Journal of Diabetes Mellitus 2 (2010) 15–19
Comparison of post amputation outcome in patients with type 2 diabetes from specialized foot care centres in three developing countries.Vijay V, Wadud JR, Madhavan S, Rajasekar S, Kumpatla S, Lutale JK, Abbas ZG. Diabetes Res Clin Pract. 2010 May;88(2):146-50
Harries AD, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, Billo N, Brostrom R, Bygbjerg IC, Fisher-Hoch S, Mori T, Ramaiya K, Roglic G, Strandgaard H, Unwin N, Vijay V, Whiting D, Kapur A. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health. 2010 Jun;15(6):659-63.
Diabetes and heart failure: complex duo. Vijay V, Deepa M. Cardiology Today 2010, 14 (3), May – June; 125 – 129.
Intra urban differences and double burden of uncer weifhr and over weight in developing world. Vijay V, Tharkar S, TAPI J 2010, 2 (2), May – Aug; 22 – 23.
Saxagliption: a New Dpp – 4 inhibitor in type 2 diabetes. Vijay V TAPI J 2010, 2 (2) May – Aug; 33 – 36.
The socioeconomics of diabetes from a developing country: a population based cost of illness study. Tharkar S, Devarajan A, Kumpatla S, Vijay V. Diabetes Res Clin Pract. 2010 Sep;89(3):334-40.
Effect of obesity on cardiovascular risk factors in urban populations in South India. Tharkar S, Vijay V. Heart Asia 2010: 2; 145 – 149.
Epidemiology of diabetic foot and management of foot problems in India.Vijay V. Int J Low Extrem Wounds. 2010 Sep;9(3):122-6.
Role of combination therapy in hypertension. Vijay V. Asian J Diabe, 2010; 12 (3), July – Sep: 13 – 17.
Insulin resistance at different stages of diabetic kidney disease in India.Vijay V, Tilak P, Meerza R, Kumpatla S. J Assoc Physicians India. 2010 Oct;58:612-5.
Liraglutide – A novel once daily human GLP-1 analogue for type 2 diabetes mellitus. Vijay V. TAPI J 2010, 2 (3) Sep – Dec; 33 – 36.
Association of non – alcoholic fatty liver disease with diabetic microvascular and macrovascular complications in south Indian diabetic subjects. Vijay V, Kaditi M, Srikant M, Satyavani K. IJDDC 2010, Oct – Dec; 30 (4): 208 – 212.
Peripheral vascular Disease.Vijay V and Balaji V Book chapeter - Prevent death caused by diabetic complications: Diabetes and complications in India - Perspective and treatment options. Elsevier 2010; 188 – 194.
Diabetic foot. Vijay V. Disease.Vijay V and Balaji V Book chapeter - Prevent death caused by diabetic complications: Diabetes and complications in India - Perspective and treatment options. Elsevier 2010; 195 – 204.
Population based prevention strategies for childhood obesity – report of the WHO forum for technical meeting. Geneva, 15 – 17 december 2009.
2011 (3Natio 8 Int nation 3 BC 6 StA l)
Cardiovascular risk factors in North Indian populations in South India vs native South indian populations. Vijay V, Tharkar S, Arutselvei D, satyavani K, Vigneswari A, Parthiban M. IJCP
Pattern and causes of amputation in diabetic patients--a multicentric study from India.Vijay V, Kumpatla S. J Assoc Physicians India. 2011 Mar;59:148-51
Efficacy of glycated albumin (GA) in comparison with glaycated haemoglobin (HbA1C) in type 2 diabetic subjects in India. Satyavani K, Tilak P, Vijay V. J Med Edu and Res, 2011: 13(2) Jan – Mar; 6 – 10.
Awareness about HbA1c test in type 2 diabetic patients during registration in a tertiary care centre in India. Srikant M, Satyavani K, Vijay V. TAPIJ 2011; 3(1): 8 – 13.
Central blood pressure lowering and cardiovascular prevention. Vijay V TAPIJ 2011; 3(1): 21 – 22.
Role of α – glucosidase inhibitors in the management of postprandial hyperglycemia. Vijay V, Asian J Diabe 2011; 13(1) Jan – Mar: 9 – 12.
Vascular changes seen in postprandial hyperglycemia. Vijay V and Divya M. Asian J Diabe 2011; 13(1): 14 – 18.
Role of triple drug combination therapy for type 2 diabetes millitus – Clinical perspective. Vijay V, Asian J Diabe 2011: 13 (2); 9 – 12.
A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers.Vijay V, Kesavan R, Kavitha KV, Kumpatla S. Indian J Med Res. 2011 Aug;134(2):168-73
Management of diabetic hypertensives. Ganesh J, Vijay V. Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4:S374-9.
Fear about marriage and conception among youth with Type 1 diabetes: An exploratory study. Sripriya Shaji, Umamahesh K, Satyavani K, Vijay V. Tapij 2011; 3(2): 1 – 6.
How far has translation of research been implemented into clinical practice in India? Are the recommended guidelines adhered to?. Tharkar S, Arutselvi D, burman H, Uma mahesh, Vijay V, IJDM 2011.
Optimal RAAS control: DRIs beyond BP reductions. TAPI J 2011 3(3), Sep – Dec; 39 - 44.
Pattern of diseases among patients attending private heath care centres in a south Indian state, tami nadu – A Study from API – TNSC. Vijay V, Ponniah S, Jadeesan KMSV, Balakeishnan K, Gurumoorthy T, pothiraju s, Ramamurthy SP, Maruthupandian M, Sundaraj T, Mathiselvan CA, Alagia Nambi P, Danial MK, Srinivas S, Eswaran P, Vigneswari A, Satyavani K. TAPI J 2011: 3(3); Sep – Dec 1 – 5.
Recent advances in management of diabetic nephropathy – An Overview. Vidya V, Yogesh NV, Georgi A, Vijay V, Mathew M. TAPIJ 2011; Vol 3(3): 22 – 32.
Changing trend in one decade in the profile of newly diagnosed subjects with type2 diabetes in India. Satyavani K, clementina M, Vigneshwari A Vijay V, Int J Diab and Metab. 2011; 19: 107 – 111.
Visceral Adiposity Index and pattern of dyslipidaemia at different stages of glucose intolerance—A study from India. Satyavani K, Clementina M, Vijay V. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2011; 5(4): 173-178.
Recent trends and future perspectives in the managemnt of peripheral neuropathy. Vijay V and Divya M. Diabetes care in India today ..and by 2025? Pub by Micro labs99 – 110. [ book chapter]
Diabtic Nephropathy: Clinical course, evaluvation, and follow-up recommendations. Singh J and Vijay V. ECAB Clinical Update: Diabetology 37 – 49. Elsevier pub. [ book chapter]
VIPs of healing diabetic foot (Vascular, infection and pressure). Vijay V, Postgraduate Medicine: Cutting edge techmology in Medicine) Vol 25, 2011 Chapter 20: 183 – 188. [ book chapter]
2012 (3 Nationa 8 Inte Nationa 0 BC 3 Sta L, 1 Coll)
Prevalence of diagnosed and undiagnosed diabetes and hypertension in India – results from the screening India’s twin epidemic (SITE) study. Shanshank R J, Banshi S, Vijay V. Diab tech and Therapeutics 2012; Vol 14 (1): 1 – 8
α2 Heremans schmid glycoprotein (AHSG) gene Thr 256 Ser polymorshism in type 2 diabetes among south Indians. Ezhilarasi K, thanigaivelan K, Parthiban M, Vijay V. Int J Cureent Res, 2012; 4(3): 107 – 111
Is HSP 70-hom (C2437T) single nuleotied polymorphism (SNP) associatd with diabetic foot u;cer (DFU) among south Indian population?. Dhamodharan u, Ezhilarasi K, Parthiban M, Rama R, Indira P, Vijay V. J Dia Foot Compli, 2012; 4 (2)No: 3 : 57 – 62.
Prevalence of diabetes and pre diabetes and associated risk factors among Tuberculosis patients in India. Vijay V, Satyavani K, Vigneswari A, Rajeswari R, Chinnaswamy C, Rajan S, Selvam J M, Kapur A. Plos ONE 2012 7 (7): 1 -8
Impact of awareness programme on prevention of childhood obesity among school children in a metropolitan city – Chennai slim and fit programme. Vignewswari A, Manikandan R, Satyavani K, Rajeswari R, Vijay V. J Edu and practice, 2012; 3 (9); 88 – 94.
Risk associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Vijay V, Tilak P, Satyavani K. IJMR, 2012; 136 (1): 46 – 53.
Association of A1538G and C2437T single nucleotide polymorphisms in heat shock protein 70 genes with type 2 diabetes. Dhamodharan U, Ezhilarasi K, Parthiban M, Rama Rajaram, Indira padmalayam, Vijay V. Labmedicine Fall 2012; 43(6): 250 – 255.
Olmesartan Medoxomil. Vijay V. TAPIJ 2012; 4(1): 20 – 21.
Linagliptin. Vijay V TAPIJ 2012; 4 (2): 14 – 17.
Bias and barriers influencing patients’ attendance towards diabetes education programme. Sripriya S, satyavani K, Vijay V. TAPJ 2010; 4 (3): 1 -7
Improving diabetes care: Multi-component cardiovascular disease risk reduction strategies for people with diabetes in south asia – The CARRS multi-centre translation trial. Shah S, Kavitha singh, Ali MK, Mohan V, Kadir MM,Unnikrishnan AG, Sahey RK, Varthakavi P,Mala D, Vijay V, Masood Q, Bantwal G, Rajesh K, Ankush D, etal. DRCP 2012; 98 : 285-294.
Evaluation of Roger’s charcot foot classification system in south Indian diabetic subjects with Charcot foot. Vijay V, Rajesh Kesavan, Kavitha KV, satyavani K. J Dia Foot Compli 2012; 4(3) No2: 67 – 70.
Subjects with Type 2diabetes may have obstructive sleep apnoea even at lower BMI values. Vijay V, Ramakrishnan N, Sunaina S, Vigneswari A, Satyavani K. Ind J Sleep Med 2012; 7(2):45 – 47.
Association of diabetes and tuberculosis--a major public health challenge. Vigneswari A, Vijay V, Kumpatla S. Indian Med Assoc. 2012 Sep;110(9):646-8.
Lipsky BN, Perters EJG, Senneville E et al. Expert opinion on the management of infections in the diabetic foot. Diabetes/Metabolism Research and Reviews 2012; 28 (Suppli 1): 163 – 178. Dr Vijay Viswanathan did the Acknowledgement in expert panel)
2013 (5natioal, 8 Int Natio 4 BC, 5 STAL)
Effect of Spironolactone and Amiloride on Thiazolidinedione – induced fluid retention in south Indian patients with type 2 Diabetes. Vijay V, Mohan V, Subramani P, Parthasarathy N,Subramaniyam G, Manoharan D, Sundaramoorthy C, Gundi L, Karalliedde J, Viberti G, Clin J Am Soc Nephrol. 2013 Feb;8(2):225-32. .
Problems associated with diabetes care in India. Vijay V, Rao VN. Diabetes Management 2013; 3(1): 31 – 40.
The cost of treating long term diabetic complications in a developing country: A study from India. Satyavani K, Hemalatha K, Tharkar S, Vijay V. JAPI. 2013: 61(2): 102 – 109.
Stromal cell – derived factor (SDF - 1β) Gene single nucleotide polymorphism st position G801A is associated with type 2 diabetes mellitus in a south Indian population. Dhamodharan U, Ezhilarasi K, parthiban M, Rama Rajaram, Indira P, Vijay V. Int J Genetic Eng 2013, 3(1): 1 – 5.
Managing diabetic foot infection in India. Vijay V, Rao VN. Int J Lower Extremity Wounds. 2013; 12(2): 158-166.PMID: 23667101
Relationship between Retinal – Renal complications among type 2 diabetic subjects in India. Vijay V, Satyavani K, Tilak P, Archana K. Int J Diab & vas disease and Res (IJDVR). 2013; 1(2): 1 – 9.
Screening of patients with diabetes mellitus for tuberculosis in India. India Diabetes Mellitus – Tuberculosis study Group. Trop Med Int Health 2013; 18(5): 646 – 54.
Comparison of exercise regime between adults with type 2 diabetes and healthy subjects. Sripriya S, Ramya G, satyavani K, Vijay V. TAPIJ Vol 5(2): 7 – 12.
Saxagliptin / Metformin: A Review. TAPIJ Vol 5(2): 23 – 25.
Case Discussion: Quiz. Vijay V and Jaiganesh M. TAPIJ Vol 5(2): 34 – 35.
Evaluation of diabetes self-care with self-monitoring of blood glucose among type 2 diabetic patients and its impact on HbA1c. Shaji S, Dhanalakshmi R, Satyavani K, Vijay V. IJDDC 2013; 33(3): 181 -182.
Insulin resistance and cardio metabolic abnormalities among overweight South Indian children: chennai slim and fit programme. Tharkar S, Devarajan A, Kumpatla S, Muthukumaran P, Vijay V. Indian J Community Med. 2013 Apr;38(2):121-2.
Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Kumpatla S, Vigneswari A, Rajan R, Vijay V, Kapur A. Diabetes Res Clin Pract. 2013 Oct;102(1):60-4.
Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India S. Kumpatla, A. Sekar, S. Achanta, B. N. Sharath, A. M. V. Kumar, A. D. Harries, Vijay V. Public Health action, 2013; 3(S1): S23 – S28.
Bioburden vs Antibiogram of diabetic foot infection. Jenifer J, Geethalakshmi S, Satyavani K, Vijay V. Clin Res Foot & ankle. 2013; 1(3) (open access)
Prevalence of residual bladder and associated risk factors in patients with type 2 diabetes seen in a tertiary care centre. Burman H, Patel R, Rekha K, Satyavani K, Suresh M, Vijay V. TAPIJ 2013; 5 (3): 6 – 11.
Case Discussion: Quiz. Vijay V and Jaiganesh M. TAPIJ 2013; 5(3); 20 – 21.
Protocol of an observational study to evaluate diabetic nephropathy through detection of microalbuminuria in Indian patients. Gokulnath, Manisha S, Sanjay K, Vijay V, A H Zargar, P G Talwalkar, Subhash Kuamr Wangnoo, Debasish Maji, G Vijay Kumar, Ramesh Kumar Deodatta Chafekar, Brij Mohan, Ganapathi Bantwal, Anil Bansali, Jasmeet Singh Sahni Indian J Endocrinol Metab 2013 May;17(3):496-504
Minimizing the risk of Hypoglycemia with Gliptins. Vijay V and Jaiganesh M. Hyperglycemic & Hypoglycemic emergencies in diabetes mellitus. 1sted, Ed by Ashok Kumar Das, 2013 published by Micro Labs Ltd (Book Chapter)
The Double Burden of tuberculosis and diabetes in India. Muruganathan A, Vijay V API – Medicine update 2013; 152 – 155. (Book Chapter)
Delivering an Effective foot care for people with Diabetes. Vijay V Chapter 50, API – Medicine Update 2013; 223 – 226. (Book Chapter)
Indian National Consensus Group: National Guidelines on initiation and intensification of insulin therapy with premixed insulin analogs. Das AK, Sahay BK, Seshiah V, Mohan V, Muruganathan A, Ajay Kumar, Vijay V etal. Chapter 51, API – Medicine Update 2013: 227 – 236. (Book Chapter)
2014 (5 Natio 5 Int nation 8 BC, 3 Sta L 1 coll)
Risk of Diabetes in Subjects with Sedentary Profession and the Synergistic Effect of Positive Family History of Diabetes. Vigneswari A, Satyavani K, Manikandan R,Rajeswari Rajan, Vijay V. Diabetes Technology & Therapeutics. 2014. Vol 16(1): 26 – 32.PMID: 24116832
Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis— A report from South India. Vijay V, Vigneswari A, Selvan K, Satyavani K,. Rajeswari R, Anil Kapur. Journal of Diabetes and Its Complications 28 (2014) 162–165. - PMID: 24461545
Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes e An 11-year follow up study. Umamahesh K, Vigneswari A, Surya Thejaswi G, Satyavani K, Vijay V. Indian heart journal 2014; 66: e 5- 10 - PMID: 24035281
Direct cost associated with chronic kidney disease among type 2 diabetic patients in India. Satyavani K, Hemalatha K, Jayaraman M, Vijay V. Indian J Nephrology 2014; 24(3): 141 – 147.
Global guideline for type 2 diabetes. International Diabetes Federation Guideline Development Group. Diabetes Res Clin Pract. 2014 Apr;104(1):1-52. -PMID: 24508150
Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Pareek A, Chandurkar N, Thomas N, Vijay V, Deshpande A, Gupta OP, Shah A, Kakrani A, Bhandari S, Thulasidharan NK, Saboo B, Devaramani S, Vijaykumar NB, Sharma S, Agrawal N, Mahesh M, Kothari K. Curr Med Res Opin. 2014 Jul;30(7):1257-66 - PMID: 24669876
Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes – A study from India. Satyavani K, Kirubakaran K, Sathyamurthy I, Parthiban M, Jayanthi K, Srinivasan KN, Vijay V. Ind J Medical Research 2014; 139: 841 – 850 - PMID: 25109718
Insulin Degludec – A novel ultra – long acting basal insulin analogue. Vijay V, TAPIJ 2014; 6(1): 6 – 10.
An aggressive and multi-pronged approach to prevent amputation in India. Vijay V. IJDDC 2014; 33(3): 123-124
An interesting case of hyponatremia. Jaiganesh M, TAPIJ 2014; 6(2): 22 – 24.
Rodiographic abnormalities in the feet of diabetic patients with neuropathy and foot ulceration. Vijay V, Satyavani K. Narayana Rao N. JAPI 2014; 62(11): 30-34 PMID: 26281477
Opportunistic screening of legal professional for diabesity and hypertension. Vijay V, Muruganathan A, Manikandan R, Vigneswari A, Satyavani K. TAPI J 2014; 6(3): 15 – 18.
A Simple and Specific Method for Estimation of Lipoic Acid in human Plasma by High Performance Liquid Chromatography. Ezhilarasi K, Sudha V, Geetha Ramachandran, Dhamodharan U, Rama Rajaram, Indira Padmalayam, Vijay V and Hemanth Kumar AK. J Chromat Separation Techniq 2014; 5( 6): 1000245 (Open Access journal)
Eﬃcacy and safety of a ﬁxed-ratio combination of insulindegludec and liraglutide (IDegLira) compared with itscomponents given alone: results of a phase 3, open-label, randomised,26-week, treat-to-target trial in insulin-naïve patients with type 2 diabetesStephen C L Gough, Bruce Bode, Vincent Woo, Helena W Rodbard, Sultan Linjawi, Pernille Poulsen, Lars H Damgaard, John B Buse, on behalf of the NN9068-3697 (DUAL-I)trial investigators. The Lancet Diabetes and Endocronology 2014; 2(11): 885 – 893. (Collabrative / Principal Invester).
Prescribing footwear. Vijay V. Contemporary management of the diabetic foot; Chapter no 20: 176 – 84, 2014. (Book chapter)
Non – insulin antihyperglycaemic management in chronic kidney disease. Vijay V. Post graduate Medicine; Chapter no 16: 167 – 78, 2014(Book chapter)
Importance of measuring urea, creatinine ACR & eGFR in DM. Vijay V, Satyavani K, Nayayan Rao V. Common pitfalls &remedies in diabetes management – A Practical guide 2014; 37 – 42. (Book Chapter)
CV effects of gliptins. Vijay V. MedicineUpdate 2014; Vol 24.2: 1480-1482. (Book Chapter)
Wound healing in diabetes. Vijay V. Uncontrolled diabetes Ed by V. Seshiah and Carl Erik Mogensen, 2014; Chapter no 11: 209 – 223. (Book Chapter) ISBN: 978-8192656779
Pathogenesis of microvascular complications of diabetes. Daya Kishore Hazra, Vijay V. Rssdi Text Book of Diabetes Mellitus, 3rd Edition, Ed by Hemrai B Chandalia, Chapter No 63: 2014; 918 – 934. (Book Chapter) ISBN : 9789351520900
Economic aspects, Insurance, Driving and employment problems in diabetes. Vijay V. Rssdi Text Book of Diabetes Mellitus, 3rd Edition, Ed by Hemrai B Chandalia, Chapter No 83: 2014; 1263 – 1273.(Book Chapter) ISBN : 9789351520900
Recent advances in diabetic foot care: the role of foot wear and orthosis by G.Saraswathy, Gautham gopalakrishna B.N, DAS and Vijay V. Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis ... edited by Anne George, Robin Augustine, Mathew Sebastia. 2014; Chapter 8 : 317-338. (Book Chapter) ISBN 9781926895765
2015(8 national , 5 Int nationa 2 BC, 2 sta L)
- Effect of a comprehensive training programme for tuberculosis health care providers and tuberculosis patients on diabetes – a report from south India. Vijay V, Vigneswari A, satyavani K, selvan K, Rajeswari R, Kapur A. Int J of Tropical Dis 2015; 5(1): 91-100
- Double burden of diabetes and TB – Experience in India. Vijay V, Satyavani S, Anitha R. Diabetes Voice 2015; 60(1): 22 – 24.
- Preventing microvascular complications in type1diabetes mellitus. Vijay V. Ind J Endo and metabolism 2015, vol 19(suppli1): S36 – 38. PMID: 25941647
- Type 1 diabetes: Awareness, management and challenges: Current scenario in India. M. Prasanna Kumar, Banshi Saboo, P.V. Rao, Archana Sarda, Vijay V, Sanjay K, Bipin Sethi, Nalini Shah, S.S. Srikanta, Sunil M Jain, P. Raghupathy, Rishi Shukla, Ashok Jhingan, Subhankar Chowdhury, P.K. Jabbar, Alok Kanungo, Rajesh Joshi, Surendra Kumar, Nikhil Tandon, Vaman Khadilkar, Manoj Chadha. Ind J Endo & Metabolism, 2015;19(supli1):S6 – 8. PMID 25941655
- Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.Grek CL, Prasad GM, Vijay V, Armstrong DG, Gourdie RG, Ghatnekar GS.Wound Repair Regen. 2015 Mar;23(2):203-12. PMID: 25703647
- Genetic association ofIL-6, TNF-α and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Dhamodharan U, Vijay V, Ezhilarasi K, Rama R, Aravindhan V. Gene, 2015 Jul 1;565(1):62-7. PMID: 25839939
- An assessment of fear of self injecting and self testing in insulin treated diabetic patients and its impact on HbA1c. Sripriya S, Anu Jij, Satyavani K, Vijay V. TapiJ 2015; 7(1): 1 – 4.
- Clinical significance of urinary liver‑type fatty acid binding protein at various stages of nephropathy Vijay V, S Sivakumar, V Sekar, D Umapathy1, S Kumpatla Ind J Nephrology 2015; 25(5): 269-273.
- Novel insulin co-formulation of insulin degludec and insulin aspart (IDegAsp): advancement in diabetes management. Vijay V. TapiJ 2015; 7(2): 1-9.
- Impact of the hypoxia inducible factor-1α (HIF-1α) pro582ser polymorphism and its gene expression on diabetic foot ulcers. Pichu S, Jayalalitha S, Ezhil K, Dhamodharan U, Vijay V. Diabetes Res Clin Pract. 2015 Sep;109(3):533-40.
- Prevalence of risk factors of diabetes among urban Poor South Indian population
A Vigneswari, R Manikandan, K Satyavani, S Archana, R Rajeswari, Vijay V. Japi 2015; 63(10): 32-34.
- Global Increase in the Prevalence of Diabetes with Special Reference to the Middle East and Asia. Vijay V, Saigopal S. Diabetes Technol Ther. 2015 Oct;17(10):676-8.
- Effect of yogasanas on glycaemic, haemodynamic and lipid profile in newly diagnosed subjects with type 2 diabetes. Satyavani K,Clementina M, Vijay V. IJDDC, 2015; 35( Suppl 2), pp 181-188
- Assessment of depression among type 2 diabetic patients with complications and without complications. Sripriya S, Elayaraja B, Satyavani K, Vijay V. IJDDC 2015,Volume 35, Issue 3, pp 310-313
- Sex differences in cardiovascular risk factors among people with diabetes in South India. Satyavani K, Archana S, Ajay MV Kumar, Shanta A, Vijay V. Japi 2015; 63(12): 20 – 24.
- Optimizing foot care in diabetes. Vijay V. Chapter 49 Medicine Update – 2015; 264-267 (Book Chapter) ISBN : 978-8192426051
- Pathogenesis of type 1 diabetes mellitus. Sanjeevi CB and Vijay V. API Text book of Medicine 10th(Book Chapter) ISBN 978-93-5152-415-1
1.Effect of structured behaviour intervention program on Childhood Obesity. Vijay V, Khan BKS, Vigneswari A, Selvan K, Rajeswari R. Saigopal S. Int J of TRO DIS & Health 2016; 11(4): 1-8.
2.Socio-Economic Factors Relating to Diabetes and its Management in India. Shrivastava U, Misra A, Gupta R, Vijay V. J Diabetes. 2016; Vol: 8(1): 12-23 PMID: 26019052
3.High Prevalence and Heterogeneity of Diabetes in TB Patients from South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, Li W, Viswanathan V. Chest. 2016; 149(6): 1501-8. PMID: 26973015
4.“Living with type 1 diabetes: Life story of Pallavi” Journal of Social Health and Diabetes / Vol 4 / Issue 1 / Jan-Jun 2016
5.Proteinuria on non diabetic patients: clinical Significance. Viswanathan V, Rani.AA. Hypertens J, 2016, 2(3):118 – 123
6.Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India. Mohan V, Sunil Jain, Jothydev K, Manoj C, Abhay M, Vijay V, Banshi S, Rajiv K, Ambrish M, Dharmen P, John S. JAPI 2016: 64(4): 16 – 21. PMID: 27734636
7.Double burden of diabetes and tuberculosis. Vijay V, Saigopal S, Satyavani K. World Clinics Diabetology 2016; 2(1): 23-29. ISBN : 9789352501649
8.Diabetes – an ancient disease, epicdemic & an economic burden for the present era. Vijay V and Smriddhi Ranjan. Ind J Med Res, 2016; 143(4): 11-13. PMID: 27377490
9.Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C – A report from South India. Satyavani K, Anju Soni, S.N. Narasingan, Vijay V. Indian Heart J. 2016 May-Jun; 68(3): 378–379. PMID: 27316499
10.Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z,Vijay V. Int J Low Extrem Wounds. 2016 Jun;15(2):102-19. Review. PMID: 27207900
11.Dual role of transforming growth factor (TGFβ) in diabetic nephropathy – A Review. Anitha rani A and Vijay V. TAPIJ 2016; 8 (1) Jan – Apirl: 5 – 10.
12.Best practices from Changing Diabetes® in Children India K. M. Prasanna Kumar, Nalini Shah, Vijay V, Archana Sarda, Shuchy Chugh, Dinakaran P. J Social Health and Diab 2016, 4 (2): 137-140
13.GLP -1 Analogs in the management of Type 2 diabetes: A Review. Vijay V. TAPIJ 2016; 8(2) May – Aug: 23 - 35
14.Effect of standard tuberculosis treatment on naive, memory and regulatory T cell homeostasis in tuberculosis-diabetes co-morbidity. Kumar NP, Moideen K Vijay V, Kornfeld H, Babu S. Immunology. 2016 Sep;149(1): 87-97. PMID: 27289086
15.Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Kleinman NJ, Shah A, Shah S, Phatak S, Vijay V. Diabetes Care. 2016 Oct;39(10): e169-70. PMID: 27493133
16.Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial. Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, Ajay VS, Unnikrishnan AG, Menon VU, Varthakavi PK, Viswanathan V, Dharmalingam M, Bantwal G, Sahay RK, Masood MQ, Khadgawat R, Desai A, Sethi B, Prabhakaran D, Narayan KM, Tandon N; CARRS Trial Group. Ann Intern Med. 2016 Sep 20; 165 (6):399-408. PMID: 27398874.
17.Replication of genome-wide association signals in Asian Indians with early-onset type 2 diabetes. Chidambaram M, Samuel Liju, Banshi Saboo, Satyavani K, Vijay V, Pankratz N, Myron Gross, Mohan V. Acta Diabetol 2016; Dec 53(6): 915 - 923. PMID:27488727
18.Glycemic index of two varities of biscuits commonly consumed among the diabetes. Patricia Trueman, Vijay V. TAPIJ 2016: 8(3) Sep - Dec: 1-5.
19.Psychological factors associated with diabetes mellitus. Jenifer M, Anitharani A, Vijay V. TAPIJ 2016; 8(3) Sep – Dec: 12 – 15.
20.Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes - A pilot study. Vijay V, Seena R, Bamila S, Satyavani K. IJMR 2016; 144(2): 215 – 219.
21.Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Kumar NP, Moideen K, Sivakumar S, Menon PA, Vijay V, Kornfeld H, Babu S. Tuberculosis (Edinb). 2016; Dec 101: 191-200. PMID: 27865391
22.Postprandial glycaemic response of foxtail millet dosa in comparison to a rice dosa in patients with type 2 diabetes. Janani N, Vimala S, Rohini U, Patricia T, Vijay V. Ind J Med Res 2016; 712-717. PMID: 28361824
I)Diabetic Foot. Vijay V, Anitha Rani. Medicine Update 2016. Vol – 26, Part . (Book Chapter) ISBN 9789352501991
II)A multidisciplinary approach to manage a patient with neuroischemic foot in a tertiary care unit. Vijay V. Diabtes Clinical case serious – I. Ed by Mohan V and Ranjit Unnikrishnan 2016; Chapter 18: 134 – 142. (Book Chapter) ISBN: 9789352500321
III)Epidemiological data of TB and DM. Vijay V and Anitha Rani A. RSSDI Monograph on Diabetes and TB. Ed by Vijay Viswanathan 2016; 6 – 11 (Book Chapter)
IV)Diagnosis of diabetes in tuberculosis patients. Satyavani K. RSSDI Monograph on Diabetes and TB. Ed by Vijay Viswanathan 2016; 30 – 35 (Book Chapter)
V)Diabetes and Clinical Complications: Neuropathy. Vijay V and Anitharani A. In Handbook on Coronary Artery Disease ed by Gundu HR Rao. Chap 15; 203 – 306 Macmillan Medical Communications, New Delhi, India. ISBN 978-93-80780-96-2 (Book Chapter)
VI)Peripheral vascular disease (PVD) in diabetes. Vijay V, Bamila S, Anitha Rani. RSSDI Hand Book of Diabetes Mellitus, Ed by Sameer Banerjee; 2016: 232 – 235. Pbu by Scientific book com.ISBN: 978-81-931825-0-5. (Book Chapter)
A.Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI-UnitedHealth Global Health Centers of Excellence Program. Engelgau MM, Sampson UK, Rabadan-Diehl C, Smith R, Miranda J, Bloomfield GS, Belis D, Narayan KM; National Health, Lung, and Blood Institute–UnitedHealth Global Health Centers of Excellence Collaborators. Glob Heart. 2016 Mar;11(1):5-15. PMID: 27102018 (Collaborators)
B.Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes. Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group. Diabetes Obes Metab. 2016 Jan;18(1):82-91. PMID: 26450639 (Collaborators)
1.Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. Kumar NP, Moideen K, Sivakumar S, Menon PA, Vijay V, Kornfeld H, Babu S. J Infect. 2017; Jan 74(1): 10 – 21 PMID: 27717783.
- Impreoved medication adherence and frequency of blood glucose self testing an m-health platform versus usual in a multisite randomizd clinical trial among people with type 2 diabetes in India. KleinmanNJ, shah A, Shah S, Phatak S, Vijay V. Telemedicine and e-Health 2017 Mar; 23(9): 1-8. PMID: 28328396
4.Association of A1538G and C2437T single nucleotide polymorphisms in heat shock protein-70 genes with diabetic nephropathy among South Indian population. Dhamodharan U, Ezhilarasi K, Ponjayanthi B, Sireesh D, Ramkumar KM, Vijay V. Biosci Rep. 2017 Mar 27;37(2). PMID: 28246355
5.Homology modeling of Homo sapiens Lipoic acid Synthase: substrate docking and insights on its binding mode. Krishnamoorthy Ezhilarsi, Hassan S, Hanna LE, Padmalayam I, Rajaram R, Vijay V. J Theor Biol. 2017 May; 420: 259-266. PMID: 27717843
- Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications. Cesar A. Prada-Medina, Kiyoshi F. Fukutani , Nathella Pavan Kumar, Leonardo GilSantana, Subash Babu, Flávio Lichtenstein, Kim West, Shanmugam Sivakumar, Pradeep A. Menon, Vijay Viswanathan, Bruno B. Andrade, Helder I. Nakaya & Hardy Kornfeld. Scientific reports 2017 May 17: 7(1): 1999. PMID: 28515464
7..A Study on positive impact of intensive psychological counseling on psychological well-being of typr 2 diabetic patients undergoing amputation. Jenifer AM, Antharani A and Vijay V. Int J of Psychology and Counse 2017, Vol 9(2). Article Number: 6A0E48164241
8.Impact of Lysyl Oxidase (G473A) Polymorphism on Diabetic Foot Ulcers. Pichu S, Jayalalitha S, Vimalraj S, Vijay V, Suvro Chatterjee. Int J Biological Macromolecules 2017; May 103: 242 – 247. PMID: 28522400
9.Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropthy.Sabitha P and Vijay V. Diabete metab J 2017 Apr, 41(2):128-134. PMID: 28447439
10.Role of molecular genetics in diabetic foot ulcer. Vijay V. Pol Arch Intern Med. 2017 May 31;127(5) May: 310-311. PMID: 28581451
11.The need for improved diabetes care in India. Vijay V. Lancet Diabetes Endocrinol. 2017; Vol. 5 (8), p566–567 PMID: 28601584
- Comparison of two creatinine based equations for routine estimation of GFR in a speciality clinic for diabetes. Satyavani K, Anjusoni, Vijay V. JAPI 2017; 65(8): 38 – 41.
- Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment. Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Menon PA, Kornfeld H, Babu S. PLoS One.2017 Sep 14;12(9):e0184753. PMID: 28910369
- Regular exercise with an active lifestyle improves the lipid profile of individuals with diabetes mellitus. Janani N, Pranisha J, Patricia T, Sriram R, Saigopal S, Vijay V. Int J Diab Dev Count 2017, Volume 37(3) Sep: 262–266
15. Stratifying renal risk and retinal involvement in South Indian type 2 diabetic patients: using the Kdigo classification. Anitharani A, Satyavani K, Vijay V. Int J Diabetol Vasc Dis Res, 2017
- Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease. Anitha Rani A, Exhilarasi K, Vijay V. Int J Diabetol Vasc Dis Res (IJDVR),. 2017;5(4):202-207.
17. Diabetic foot ulcers—comparison of performance of ankle-brachial index and transcutaneous partial oxygen pressure in predicting outcome. Chitra R, Vijay V, Seena R, Bamila S, Linu daniel. Int J Diab Dev Count
Sep Online ahead.
18. RSSDI clinical practice recommendations for diagnosis, prevention, and control of the diabetes mellitus-tuberculosis double burden. Vijay V, Sarita B et al International Journal of Diabetes in Devel… (2017) Sep Online ahead.
- a) Newer Technologies in diabetic foot ulcer prevention. Vijay V, Anitha Rani A, Khan BKS, Linu Daniel. Chapter 47, RSSDI Diabetes Update – 2016 Ed by Madhu SV, Jaypee brothers; 2017: 247 - 251. ISBN No: 978-93-86261-14-4(Book Chapter)
- b) Glycated Hemoglobin. Barman H. Chap 5, Monograph – Practicle pearls in diabetes. Ed by Vijay V and Prakash G, Jaypee brothers. 2017: 29 – 31. ISBN:978-93-86261-41-0 (Book Chapter)
- c) Diabetic Nephropathy: Practical Pearls. Vijay V and Anitharani A. Chap 8, Monograph – Practicle pearls in diabetes. Ed by Vijay V and Prakash G, Jaypee brothers. 2017: 42 – 45. ISBN:978-93-86261-41-0 (Book Chapter)
- d) Diabetic Neuropathy: Practical Pearls. Vijay V and Anitharani A. Chap 9, Monograph – Practicle pearls in diabetes. Ed by Vijay V and Prakash G, Jaypee brothers. 2017: 46 – 50. ISBN:978-93-86261-41-0 (Book Chapter)
- e) Diabetic Foot Syndrome: Practical Pearls. Vijay V and Anitharani A. Chap 10, Monograph – Practicle pearls in diabetes. Ed by Vijay V and Prakash G, Jaypee brothers. 2017: 51-55. ISBN:978-93-86261-41-0 (Book Chapter)
- f) Insulin Therapy in diabetes Mellitus. Jaiganesh M. Chap 14, Monograph – Practicle pearls in diabetes. Ed by Vijay V and Prakash G, Jaypee brothers. 2017: 85-91. ISBN:978-93-86261-41-0 (Book Chapter)
Role of biomarkers in predicting diabetes complications with special reference to diabetic foot ulcers. Pichu S, Patel BM, Apparsundaram S, Goyal RK. Biomark Med. 2017 Apr; 11(4):377-388. PMID: 28326825 (Acknowledgement)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. N Engl J Med. 2017 Aug 17;377(7):644-657.
a) Microvascular Complicatoins. Vijay V. Chapt 23, CDiC Textbook of Pediatric Diabetes Ed by Das AK and Kalra S pub by Jaypee. 2018: 215 – 221. ISBN : 978-93-5270-086-8
The new CSS cleaner allows you to organize your style sheets.